What question did this study set out to answer?

To defend the methodological validity and clinical findings of a propensity score-matched analysis comparing sugammadex to traditional reversal agents regarding postoperative pulmonary complications following upper gastrointestinal endoscopy.

August 16, 2026Anaesthesia

Sugammadex and postoperative pulmonary complications after upper gastrointestinal endoscopy: a reply

View Full Paper

Ask AI

Bookmark

Authors

YTYung‐Fong TsaiChang Gung University KHKuo‐Chuan Hung SWShao‐Chun WuChang Gung University

Discussion

Member takes

Implication

Propensity score-matched analysis demonstrates lower pulmonary complications with sugammadex after upper gastrointestinal endoscopy, suggesting effective reversal mitigates residual weakness.

Key Points

To defend the methodological validity and clinical findings of a propensity score-matched analysis comparing sugammadex to traditional reversal agents regarding postoperative pulmonary complications following upper gastrointestinal endoscopy.
Analyzed propensity score-matched cohorts from the TriNetX federated health network, balancing covariates including COPD, asthma, obesity, and age (standardized mean differences < 0.10).
Evaluated respiratory and non-respiratory endpoints over a standardized 30-day window following StEP-COMPAC consensus definitions.
Sugammadex was associated with significantly lower rates of lung atelectasis (6.74% vs. 7.76%, p = 0.014) and unplanned ICU admissions (8.27% vs. 9.45%, p = 0.009) in the matched cohort.
Non-invasive ventilation was significantly less frequent with sugammadex among patients without chronic pulmonary disease (1.93% vs. 2.70%, p = 0.013).
Outcomes without a direct mechanistic link to neuromuscular recovery, including postoperative nausea, vomiting, and arrhythmias, showed no significant differences between cohorts.

Cite This Study

Tsai et al. (2026) studied this question.

synapsesocial.com/papers/6a817a21f2fb91fc834adb74 https://doi.org/10.1111/anae.70357

View Full Paper

Ask AI

Bookmark

August 16, 2026Anaesthesia

Sugammadex and postoperative pulmonary complications after upper gastrointestinal endoscopy: a reply

View Full Paper

Ask AI

Bookmark

Authors

YTYung‐Fong TsaiChang Gung University KHKuo‐Chuan Hung SWShao‐Chun WuChang Gung University

Discussion

Member takes

Implication

Propensity score-matched analysis demonstrates lower pulmonary complications with sugammadex after upper gastrointestinal endoscopy, suggesting effective reversal mitigates residual weakness.

Key Points

To defend the methodological validity and clinical findings of a propensity score-matched analysis comparing sugammadex to traditional reversal agents regarding postoperative pulmonary complications following upper gastrointestinal endoscopy.
Analyzed propensity score-matched cohorts from the TriNetX federated health network, balancing covariates including COPD, asthma, obesity, and age (standardized mean differences < 0.10).
Evaluated respiratory and non-respiratory endpoints over a standardized 30-day window following StEP-COMPAC consensus definitions.
Sugammadex was associated with significantly lower rates of lung atelectasis (6.74% vs. 7.76%, p = 0.014) and unplanned ICU admissions (8.27% vs. 9.45%, p = 0.009) in the matched cohort.
Non-invasive ventilation was significantly less frequent with sugammadex among patients without chronic pulmonary disease (1.93% vs. 2.70%, p = 0.013).
Outcomes without a direct mechanistic link to neuromuscular recovery, including postoperative nausea, vomiting, and arrhythmias, showed no significant differences between cohorts.

Cite This Study

Tsai et al. (2026) studied this question.

synapsesocial.com/papers/6a817a21f2fb91fc834adb74 https://doi.org/10.1111/anae.70357

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark